ONCY - Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q3 2021 Results - Earnings Call Transcript

Oncolytics Biotech Inc. (ONCY) Q3 2021 Earnings Conference Call November 5, 2021 08:00 ET Company Participants Jon Patton - Director of Investor Relations & Communications Matt Coffey - President, Chief Executive Officer & Director Tom Heineman - Global Head of Clinical Development & Operations Andrew de Guttadauro - Global Head of Business Development Kirk Look - Chief Financial Officer Conference Call Participants John Newman - Canaccord Genuity Patrick Trucchio - H.C. Wainwright Presentation Operator Good morning and welcome to Oncolytics Biotech's Third Quarter 2021 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of the call. Please be advised that this call is being recorded at the company's request. And I would like to turn the call over to Jon Patton, Director of Investor Relations and Communications. Please go ahead. Jon Patton Thank you, operator and good morning, everyone. Earlier

For further details see:

Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q3 2021 Results - Earnings Call Transcript